U.S. Markets open in 2 hrs 26 mins

GenMark Diagnostics, Inc. (GNMK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.79+0.29 (+2.15%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.50
Open13.59
Bid3.00 x 1000
Ask0.00 x 800
Day's Range13.53 - 14.09
52 Week Range3.36 - 20.88
Volume316,489
Avg. Volume960,531
Market Cap989.033M
Beta (5Y Monthly)3.04
PE Ratio (TTM)N/A
EPS (TTM)-0.39
Earnings DateMar 01, 2021 - Mar 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.60
  • GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum
    GlobeNewswire

    GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum

    CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canaccord Virtual MedTech & Diagnostics Forum. GenMark’s management team is scheduled to present in a virtual setting on Thursday, November 19th, 2020 at 2:00 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.ABOUT GENMARKGenMark is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.  For more information, visit www.genmarkdx.com.Investor Relations Contact Leigh Salvo (415) 937-5404 ir@genmarkdx.com

  • GenMark Diagnostics, Inc. (NASDAQ:GNMK) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
    Simply Wall St.

    GenMark Diagnostics, Inc. (NASDAQ:GNMK) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

    As you might know, GenMark Diagnostics, Inc. (NASDAQ:GNMK) just kicked off its latest third-quarter results with some...

  • GenMark Diagnostics Inc (GNMK) Q3 2020 Earnings Call Transcript
    Motley Fool

    GenMark Diagnostics Inc (GNMK) Q3 2020 Earnings Call Transcript

    Please note that this call is being recorded today, Wednesday, October 28, 2020 at 1:30 PM Pacific Time and that will be available on the Investors section of GenMark's website at www.genmarkdx.com. Before we begin, I would like to inform you that certain statements made by GenMark during the course of this call may constitute forward-looking statements. Any statement about our expectations, beliefs, plans, objectives, assumptions or future events or performance are forward-looking statements.